Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Resistance to anti-leprosy drugs in multi-bacillary leprosy patients: The need for transformative action

Jindal R, Singh I, Goyal D, et al. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2025;
Download PDF
Publication

Doenças infecciosas negligenciadas (como hanseníase e leishmaniose): uma abordagem multiprofissional em áreas endêmicas

Nascimento MEBD, Silva NRD, Melo TMD, et al. Brazilian Journals. REVISTA DELOS. 2025; 18 (73) : 1-15.
Download PDF
Publication

Epidemiological profile of leprosy at the Hôpital de la Rive, City province of Kinshasa, Democratic Republic of Congo

Odimba Tundanonga R, Katabayi Mbiya A, Matshoko Limonge A, et al. Our Dermatology Online. Our Dermatology Online. 2025; 16 (Supp 3) : 59-65.
Download PDF
Publication

Editor’s Choice – September 2025

Lepra . Lepra. Leprosy Review. 2025; 96 (3) : 1-2.
Download PDF
Publication

Infrared thermography: a scoping review of its possible role in the diagnosis and follow-up of leprosy neuropathy

Wim Brandsma J, Knulst-Verlaan C, Knulst AJ, et al. Lepra. Leprosy Review. 2025; 96 (3) : 1-10.
Download PDF
Publication

Demographic and clinical profile of leprosy patients in Lagos, Nigeria: a 17-year retrospective study

Cole-Adeife O, Dairo G, Agaga L, et al. Oxford University Press (OUP). Clinical and Experimental Dermatology. 2025;
Publication

Validation of the Hausa version of the EMIC-CSS and SDS among adults in Northern Nigeria

Dahiru T, Murphy-Okpala N, Abdullahi S, et al. Lepra. Leprosy Review. 2025; 96 (3) : 1-10.
Download PDF
Publication

Missed or misjudged? Revisiting Leprosy Through Six Cases: A Case Series of long-standing diagnostic dilemma in Patients of North India

Rawat P, Mishra R. European Journal of Cardiovascular Medicine. 2025;
Download PDF
Publication

Impact of protein prenylation inhibition on Mycobacterium leprae viability and IL-1ß production in infected macrophages

da Silva Rocha M, Rodrigues Pereira AM, Freire dos Santos PM, et al. American Society for Microbiology. Journal of Bacteriology. 2025; 207 (9) : 1-17.
Download PDF
Publication

Lepromatous leprosy: case report

Ramos-Aguila YDLC, Hernández-Ramos Y, Cuello-Carballo MB. AG Editor (Argentina). South Health and Policy. 2026;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 6
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD